Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 11 | $7,087,280 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
13 Dec 2024 19:53 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 12 Dec 2024 | Sale | 117,333 | 12.2653 | 1,439,124 | D |
13 Dec 2024 19:53 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 13 Dec 2024 | Sale | 27,272 | 12.0625 | 328,968 | D |
12 Dec 2024 17:41 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 10 Dec 2024 | Sale | 50,000 | 13.1525 | 657,625 | D |
06 Dec 2024 19:15 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 04 Dec 2024 | Sale | 45,000 | 13.9543 | 627,944 | D |
06 Dec 2024 19:15 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 05 Dec 2024 | Sale | 49,640 | 14.1346 | 701,642 | D |
06 Dec 2024 19:15 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 06 Dec 2024 | Sale | 50,000 | 14.2323 | 711,615 | D |
04 Dec 2024 21:45 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 02 Dec 2024 | Sale | 45,000 | 13.6715 | 615,218 | D |
04 Dec 2024 21:45 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 03 Dec 2024 | Sale | 45,000 | 13.1867 | 593,402 | D |
27 Nov 2024 16:11 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 25 Nov 2024 | Sale | 32,814 | 14.0008 | 459,422 | D |
27 Nov 2024 16:11 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 26 Nov 2024 | Sale | 42,186 | 14.0466 | 592,570 | D |
27 Nov 2024 16:11 | SPRY | ARS Pharmaceuticals Inc | CHAKMA JUSTIN | Chief Business Officer | 27 Nov 2024 | Sale | 25,000 | 14.39 | 359,750 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)